HomeResMed Inc - US (RMD) Market Cap

ResMed Inc - US (RMD) Market Cap

Track the latest market capitalisation and see how the company's value has changed over time.

ResMed Inc - US's market cap September 2026

As of 07 September 2026, ResMed Inc - US's market cap was $33.18B

This places ResMed Inc - US among the largest companies by market capitalisation.

Market cap (market capitalisation) is the total value of a company's shares on the stock market – calculated by multiplying the number of outstanding shares by its current share price.

Fiscal year-end RMD market cap

The table below shows ResMed Inc - US's fiscal year-end market capitalisation, providing a reference point for its valuation aligned with its financial reporting periods. This helps illustrate how the company's market value has evolved across different years of operation.

Date	ResMed Inc - US market cap (USD)	Change (%)
June 2025	$37.83B	+34.53%
June 2024	$28.12B	-12.41%
June 2023	$32.10B	+4.69%
June 2022	$30.67B	N/A

Market capitalisation of similar companies

The table below shows other leading companies in the same sector include Biogen, Illumina, 10x Genomics, and Align Technology.

Name	Market Capitalization
Biogen	$32.36B
Illumina	$33.40B
10x Genomics	$7.93B
Align Technology	$11.37B

Data is sourced from public company disclosures, including SEC filings and EDGAR. It is provided for informational purposes only and does not constitute investment advice or a recommendation to trade. Figures are believed to be accurate at the stated dates but may change without notice.

Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.

FAQ

What is ResMed Inc - US's current market cap?

As of 07 September 2026, ResMed Inc - US's market capitalisation is approximately $33.18B. However, it's important to note that market cap values fluctuate daily based on share price movements.

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.